February
20
TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering
WESTMINSTER, Colo.–(BUSINESS WIRE)–Feb. 20, 2026– TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.